Skip to main content

What you don’t know about Martin Shkreli — his investing tips and strategies

The ‘pharma bro’ might be mired in controversy, but he has valuable investing insights, writes Michael Brush.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.